CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-16 | Heier Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +26,800 | 26,800 | ||
| 2022-05-12 | LINDSTROM RICHARD L MD Director | Exercise or conversion | +9,469 | $1.22 | $12K | 99,469 |
| 2022-05-12 | LINDSTROM RICHARD L MD Director | Exercise or conversion · Stock Option (Right to Buy) | −9,469 | 0 | ||
| 2022-05-12 | Heier Jeffrey S. Director | Purchase | +15,000 | $3.05 | $46K | 39,000 |
| 2022-02-23 | SUMMER ROAD LLC 10% owner | Purchase | +10,000 | $4.80 | $48K | 5,944,761 |
| 2022-02-18 | SUMMER ROAD LLC 10% owner | Purchase | +40,000 | $5.00 | $200K | 5,934,761 |
| 2022-02-03 | Notman Donald Chief Financial Officer | Grant or award | +55,556 | 81,632 | ||
| 2022-02-03 | Notman Donald Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +166,667 | 166,667 | ||
| 2022-02-03 | Strassburger Philip C. General Counsel | Grant or award | +50,000 | 51,810 | ||
| 2022-02-03 | Strassburger Philip C. General Counsel | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-02-03 | White Christopher G Chief Business Officer | Grant or award | +50,000 | 52,127 | ||
| 2022-02-03 | White Christopher G Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-02-03 | Goldstein Michael H. President, Ophthalmology & CMO | Grant or award | +63,333 | 313,335 | ||
| 2022-02-03 | Goldstein Michael H. President, Ophthalmology & CMO | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2022-02-03 | Mattessich Antony C. President and CEO | Grant or award | +186,750 | 289,650 | ||
| 2022-02-03 | Mattessich Antony C. President and CEO | Grant or award · Stock Option (Right to Buy) | +560,200 | 560,200 | ||
| 2022-01-28 | SUMMER ROAD LLC 10% owner | Purchase | +4,023 | $5.20 | $21K | 5,894,761 |
| 2022-01-27 | SUMMER ROAD LLC 10% owner | Purchase | +1,477 | $5.20 | $8K | 5,890,738 |
| 2022-01-24 | SUMMER ROAD LLC 10% owner | Purchase | +44,400 | $5.31 | $236K | 5,889,261 |
| 2022-01-21 | SUMMER ROAD LLC 10% owner | Purchase | +12,152 | $5.56 | $68K | 5,844,861 |
Page 13 of 17 · 327 trades